News / Press Release
Monday, 22th April 2024
Recall of pms-Duloxetine Delayed-release Capsules 60mg
The Department of Health (DH) today (22th Apr 2024) endorsed Trenton-BOMA Limited (T-BOMA), to voluntarily recall one batch of pms-Duloxetine Delayed-release Capsules 60mg from the market as a precautionary measure due to the nitrosamine result above the interim limit for the Canadian market.
Name of Product: pms-Duloxetine Delayed-release Capsules 60mg
HK Registration Number: HK-65447
Batch Number: 640627
Expiry Date: 30/04/2025
The above product, containing duloxetine hydrochloride, is a prescription medicine indicated for the treatment of depression. The above batch of product has been imported into Hong Kong and supplied to the private doctors, pharmacies and veterinary.
T-BOMA has set up a dedicated Recall hotline (852-2370 2092) to handle related enquiries.
So far, T-BOMA has not received any adverse reaction reports in connection with the impacted batch. T-BOMA will closely monitor the recall and report to DH as appropriate.
Recall of pms-Duloxetine Delayed-release Capsules 60mg
The Department of Health (DH) today (22th Apr 2024) endorsed Trenton-BOMA Limited (T-BOMA), to voluntarily recall one batch of pms-Duloxetine Delayed-release Capsules 60mg from the market as a precautionary measure due to the nitrosamine result above the interim limit for the Canadian market.
Name of Product: pms-Duloxetine Delayed-release Capsules 60mg
HK Registration Number: HK-65447
Batch Number: 640627
Expiry Date: 30/04/2025
The above product, containing duloxetine hydrochloride, is a prescription medicine indicated for the treatment of depression. The above batch of product has been imported into Hong Kong and supplied to the private doctors, pharmacies and veterinary.
T-BOMA has set up a dedicated Recall hotline (852-2370 2092) to handle related enquiries.
So far, T-BOMA has not received any adverse reaction reports in connection with the impacted batch. T-BOMA will closely monitor the recall and report to DH as appropriate.